Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)-Reference-Cited by-同舟云学术

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

Published:2018-04-27 Issue:8 Volume:73 Page:2147-2151
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Lambert-Niclot S¹,Grude M²,Chaix M L³,Charpentier C⁴,Reigadas S⁵,Le Guillou-Guillemette H⁶,Rodallec A⁷,Amiel C⁸,Maillard A⁹,Dufayard J¹⁰,Mourez T¹¹,Mirand A¹²,Guinard J¹³,Montes B¹⁴,Vallet S¹⁵,Marcelin A G¹⁶,Descamps D⁴,Flandre P²^ORCID,Delaugerre C³,Morand-Joubert L¹,Alloui Chakib,Descamps Diane,Charpentier Charlotte,Visseaux Benoit,Krivine Anne,Bouviers-Alias Magali,Pallier Coralie,Soulie Cathia,Wirden Marc,Marcelin Anne-Genevieve,Calvez Vincent,Morand-Joubert Laurence,Lambert-Niclot Sidonie,Fofana Djeneba,Mahjoub Nadia,Delaugerre Constance,Chaix Marie-Laure,Amiel Corinne,Schneider Veronique,Roussel Catherine,Le Guillou-Guillemette Helene,Courdavault Laurence,Reigadas Sandrine,Recordon-Pinson Patricia,Fleury Herve,Vallet Sophie,Dina Julia,Vabret Astrid,Mirand Audrey,Henquell Cecile,Auvray Christelle,De Rougemont Alexis,Giraudon Helene,Si-Mohammed Ali,Mathez Dominique,Signori-Schmuck Anne,Morand Patrice,Bocket Laurence,Trabaud Mary Anne,Montés Brigitte,Le Guen Laura,Rodallec Audrey,Ferre Virginie,Jeulin Helene,Schvoerer Evelyne,Dufayard Jacqueline,Allardet-Servent Annick,Carles Marie-Josee,Guinard Jerome,Guigon Aurelie,Giraudeau Genevieve,Beby-Defaux Agnes,Maillard Anne,Plantier Jean Christophe,Leoz Marie,Mourez Thomas,Bourlet Thomas,Fafi-Kremer Samira,Chiabrando Julie,Raymond Stephanie,Izopet Jacques,Barin Francis,Marque-Juillet Stephanie,Yerly Sabine,

Affiliation:

1. Sorbonne University, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Service de Virologie, APHP, Hôpital Saint-Antoine, INSERM UPMC UMR_S, Paris, France

2. INSERM UPMC UMR_S, Paris, France

3. Hôpital Saint-Louis, Université Paris Diderot, INSERM, Paris, France

4. IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Laboratoire de Virologie, Hôpital Bichat, AP-HP, Paris, France

5. Hôpital Pellegrin, Centre de ressources biologiques plurithématique, CHU de Bordeaux, Bordeaux, France

6. CHU Angers, Angers, France

7. CHU Hôtel Dieu, Nantes, France

8. Hôpital Tenon, UPMC, CR7, Paris, France

9. Hôpital Pontchaillou, Rennes, France

10. CHU Nice, Nice, France

11. CHU Charles Nicolle, Rouen, France

12. CHU Clermont-Ferrand, Clermont-Ferrand, France

13. Hôpital La Source—CHR Orléans, Orléans, France

14. Hôpital Saint-Eloi, Montpellier, France

15. CHRU La Cavale Blanche, Brest, France

16. Sorbonne University, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Service de Virologie, APHP Hôpital Pitié-Salpêtrière, Paris, France

Funder

Agence Nationale de Recherches sur le SIDA et les Hépatites virales

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/8/2147/25178721/dky142.pdf

Reference19 articles.

1. Protease inhibitor-based regimens for HIV therapy: safety and efficacy;Walmsley;J Acquir Immune Defic Syndr,2007

2. Forgiveness of non-adherence to HIV-1 antiretroviral therapy;Shuter;J Antimicrob Chemother,2008

3. Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients;Zeldin;J Antimicrob Chemother,2004

4. A Phase III comparative study of the efficacy and tolerability of three non-nucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naïve HIV-1-infected volunteers: a randomized, controlled trial;Lennox;Ann Intern Med,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Assessment of Virological Failure and Antiretroviral Drug Resistance among Treatment-naive Subjects Living with HIV;Current HIV Research;2023-09-05

2. Atazanavir;Reactions Weekly;2018-11